65 related articles for article (PubMed ID: 27993377)
1. Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.
Jiwangga D; Cho S; Kim K; Jheon S
Ann Thorac Surg; 2017 Apr; 103(4):1126-1131. PubMed ID: 27993377
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis based on the maximum standard unit value of
Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
[TBL] [Abstract][Full Text] [Related]
3. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
[TBL] [Abstract][Full Text] [Related]
4. Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.
Kameda K; Eguchi T; Lu S; Qu Y; Tan KS; Kadota K; Adusumilli PS; Travis WD
J Thorac Oncol; 2018 Dec; 13(12):1919-1929. PubMed ID: 30195703
[TBL] [Abstract][Full Text] [Related]
5. Prediction of visceral pleural invasion of clinical stage I lung adenocarcinoma using thoracoscopic images and deep learning.
Shimada Y; Ojima T; Takaoka Y; Sugano A; Someya Y; Hirabayashi K; Homma T; Kitamura N; Akemoto Y; Tanabe K; Sato F; Yoshimura N; Tsuchiya T
Surg Today; 2024 Jun; 54(6):540-550. PubMed ID: 37864054
[TBL] [Abstract][Full Text] [Related]
6. Lung adenocarcinoma with micropapillary and solid patterns: Recurrence rate and trends.
Takeno N; Tarumi S; Abe M; Suzuki Y; Kinoshita I; Kato T
Thorac Cancer; 2023 Oct; 14(30):2987-2992. PubMed ID: 37658844
[TBL] [Abstract][Full Text] [Related]
7. Pleural Carcinoembryonic Antigen and Maximum Standardized Uptake Value as Predictive Indicators of Visceral Pleural Invasion in Clinical T1N0M0 Lung Adenocarcinoma.
Na HR; Moon SW; Kim KS; Moon MH; Hyun K; Yoon SK
J Chest Surg; 2024 Jan; 57(1):44-52. PubMed ID: 38174890
[TBL] [Abstract][Full Text] [Related]
8. A CT-based deep learning model: visceral pleural invasion and survival prediction in clinical stage IA lung adenocarcinoma.
Lin X; Liu K; Li K; Chen X; Chen B; Li S; Chen H; Li L
iScience; 2024 Jan; 27(1):108712. PubMed ID: 38205257
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
Xu SJ; Chen C; Tu JH; You CX; Chen RQ; Zhang ZF; Chen SC
Ann Surg Oncol; 2024 Feb; 31(2):872-882. PubMed ID: 37962740
[TBL] [Abstract][Full Text] [Related]
10. High-risk characteristics of pathological stage I lung adenocarcinoma after resection: patients for whom adjuvant chemotherapy should be performed.
Wu LL; Jiang WM; Qian JY; Tian JY; Li ZX; Li K; Ma GW; Xie D; Chen C
Heliyon; 2023 Dec; 9(12):e23207. PubMed ID: 38144332
[TBL] [Abstract][Full Text] [Related]
11. Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study.
Huang Z; Chen D; Hong Z; Kang M
BMC Pulm Med; 2023 Oct; 23(1):417. PubMed ID: 37907906
[TBL] [Abstract][Full Text] [Related]
12. Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
Bribriesco A
Ann Thorac Surg; 2024 Jun; 117(6):1119-1120. PubMed ID: 37479128
[No Abstract] [Full Text] [Related]
13. Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion.
Ruan Z; Zhuo X; Xu C
Front Oncol; 2023; 13():1310471. PubMed ID: 38288109
[TBL] [Abstract][Full Text] [Related]
14. Relative Loss of Small Pulmonary Vessels on Imaging and Risk of Recurrence of Resected Lung Adenocarcinoma.
Synn AJ; Litchman TD; De Margerie-Mellon C; Bankier AA; Rahaghi FN; Washko GR; San José Estépar R; VanderLaan PA; Rice MB
Ann Am Thorac Soc; 2023 Nov; 20(11):1673-1676. PubMed ID: 37590317
[No Abstract] [Full Text] [Related]
15. The impact of vascular division sequence and epithelial-mesenchymal transition status on postoperative recurrence in lung adenocarcinoma.
Nishikawa S; Menju T; Takahashi K; Sowa T; Yoshizawa A; Date H
Asian Cardiovasc Thorac Ann; 2024 Mar; 32(2-3):123-132. PubMed ID: 38254290
[TBL] [Abstract][Full Text] [Related]
16. A new model using deep learning to predict recurrence after surgical resection of lung adenocarcinoma.
Kim PJ; Hwang HS; Choi G; Sung HJ; Ahn B; Uh JS; Yoon S; Kim D; Chun SM; Jang SJ; Go H
Sci Rep; 2024 Mar; 14(1):6366. PubMed ID: 38493247
[TBL] [Abstract][Full Text] [Related]
17. High-Risk Features Associated with Recurrence in Stage I Lung Adenocarcinoma.
Fick CN; Dunne EG; Vanstraelen S; Toumbacaris N; Tan KS; Rocco G; Molena D; Huang J; Park BJ; Rekhtman N; Travis WD; Chaft JE; Bott MJ; Rusch VW; Adusumilli PS; Sihag S; Isbell JM; Jones DR
J Thorac Cardiovasc Surg; 2024 May; ():. PubMed ID: 38788834
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Pleural Lavage Cytology According to Thin-Section Computed Tomography in Non-Small-Cell Lung Cancer.
Nonaka Y; Isaka M; Matsushima K; Katsumata S; Konno H; Mizuno T; Nagata T; Notsu A; Tone K; Kawata T; Endo M; Ohde Y
Clin Lung Cancer; 2024 Apr; ():. PubMed ID: 38762395
[TBL] [Abstract][Full Text] [Related]
19. [Discussion on several issues concerning minimally invasive adenocarcinoma of the lung].
Xie HK; Wu CY
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1083-1089. PubMed ID: 37899312
[TBL] [Abstract][Full Text] [Related]
20. Navigating uncertainties: recurrence challenges in early-stage non-small-cell adenocarcinoma.
Parissis H; Baranowski R; McGonigle N
Eur J Cardiothorac Surg; 2023 Nov; 64(5):. PubMed ID: 37882770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
